Pharmacogenetic landscape of epidermal growth factor receptor mutations in Kurdish non-small cell lung cancer patients: implications for precision oncology.

Ecancermedicalscience · 2026 · PMC13161589 · PMID 42131887

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Treatment-naive patients showed a trend toward higher EGFR+ rates (66.7% versus 33.3% in pre-treated cases), emphasising the importance of early molecular testing before therapy initiation.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.